YYSW001
YYSW001 is a selective and orally acrive JAK1 inhibitor with an IC50 of 6 nM and a Kd of 32.32 μM. YYSW001 blocks JAK1-dependent phosphorylation of STAT6, as well as IL-6-induced phosphorylation of STAT3. YYSW001 suppresses pro-inflammatory cytokine levels, reduces paw swelling, lowers clinical arthritis scores, alleviates joint damage and decreases bone loss. YYSW001 is applicable for the research of rheumatoid arthritis.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2763672-36-0
- 화학식: C18H20F5N5O
- 분자량:417.38
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- 순도&문서
- References
-
Help & FAQs
Biological Activity
|
JAK1 |
STAT3 |
STAT6 |
YYSW001 (2 h) potently inhibits the JAK1-dependent STAT6 pathway in THP-1 cells (IC50 = 0.041 μM), while only exerting weak inhibitory activity against the JAK2-dependent STAT5 pathway in TF-1 cells (IC50 = 5.530 μM)[1].
YYSW001 (72 h) potently inhibits the proliferation of Ba/F3-TEL-JAK1 cells (IC50 = 290.2 nM), while exhibits extremely low activity against Ba/F3-TEL-JAK2, Ba/F3-TEL-JAK3 and Ba/F3-TEL-TYK2 cells[1].
YYSW001 (15 min) inhibits IL-6-induced JAK1-dependent STAT3 phosphorylation in human whole blood cells (IC50 = 7065.0 nM in CD3+ T cells, 3001.0 nM in CD14+ monocytes), and shows extremely weak inhibitory activity against GM-CSF-induced JAK2-dependent STAT5 phosphorylation[1].
YYSW001 exhibits favorable in vitro ADME properties, including excellent liver microsomal stability and plasma stability, extremely low inhibitory activity against CYP3A4 and hERG, moderate permeability, and moderate plasma protein binding rate[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Ba/F3-engineered cell lines (Ba/F3-TEL-JAK1, Ba/F3-TEL-JAK2, Ba/F3-TEL-JAK3, Ba/F3-TEL-TYK2)
-
Concentration:serial 2- or 3-fold dilutions (nine gradients)
-
Incubation Time:72 h
-
Result:Exhibited potent inhibitory activity against Ba/F3-TEL-JAK1 cells with an IC50 of 290.2 nM.
Showed negligible inhibition against Ba/F3-TEL-JAK2, Ba/F3-TEL-JAK3, and Ba/F3-TEL-TYK2 cells (IC50 > 10000.0 nM for all three cell lines).
Achieved a cellular JAK1/JAK2 selectivity ratio of 38.6.
| Species | Dose | Route | AUC0-t | AUC0-∞ | Cmax | Tmax | T1/2 | MRT0-∞ | V | CL | F | Vd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rat[1] | 3 mg/kg | i.v. | 3831.25 h·μg/L | 4051.12 h·μg/L | / | / | 2.8 h | 3.7 h | / | 0.7 L/h/kg | / | 3.1 L/kg |
| Rat[1] | 3 mg/kg | p.o. | 2277.65 h·μg/L | 2503.58 h·μg/L | 328.61 μg/L | 3.0 h | 2.8 h | 5..8 h | 5.0 L/kg | 1.2 L/h/kg | 61.8 % | / |
| Rat[1] | 10 mg/kg | p.o. | 8543.24 h·μg/L | 8861.88 h·μg/L | 1323.53 μg/L | 3.2 h | 2.2 h | 5.0 h | 3.6 L/kg | 1.1 L/h/kg | 65.6 % | / |
| Rat[1] | 30 mg/kg | p.o. | 25905.37 h·μg/L | 26291.77 h·μg/L | 3300.77 μg/L | 2.9 h | 2.5 h | 6.6 h | 3.3 L/kg | 0.9 L/h/kg | 64.9 % | / |
YYSW001 (1-30 mg/kg; p.o.; twice daily; 14 days) exhibits a clear dose-dependent anti-arthritic effect in a rat adjuvant-induced arthritis model[1].
YYSW001 (100-200 mg/kg; p.o.; once daily; 7 days) shows no significant safety concerns in rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (SD) rats (collagen-induced arthritis model)[1]
-
Dosage:3 mg/kg; 10 mg/kg
-
Administration:i.g.; twice daily; 14 days
-
Result:Reversed disease-induced body weight loss.
Significantly reduced hind paw swelling
Decreased clinical arthritis scores.
Suppressed serum levels of pro-inflammatory cytokines IL-6, IL-1β, and TNF-α to near-normal levels.
Substantially preserved joint architecture and reduced bone loss compared to the vehicle group.
Chemical Information
-
CAS No. 2763672-36-0
-
분자량 417.38
-
화학식 C18H20F5N5O
-
SMILES
O[C@@H](C1=NC2=CN=C3NC=CC3=C2N1[C@@H]4CN(CC4)CCC(C(F)(F)F)(F)F)C
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
YYSW001 Related Classifications
HY-182359 Related Classifications
Powered by Bioz